DB
MRNA icon

Dmitry Balyasny’s Moderna MRNA Stock Holding History

Dmitry Balyasny’s Portfolio MRNA Stock Details MRNA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$1.58M Buy
+22,600
New +$1.17M ﹤0.01% 1947
2026
Q1 		– Sell
-76,400
Closed -$2.25M – 3282
2025
Q4 		$2.25M Buy
76,400
+59,700
+357% +$1.62M ﹤0.01% 1797
2025
Q3 		$431K Sell
16,700
-145,600
-90% -$4.06M ﹤0.01% 2450
2025
Q2 		$4.48M Buy
162,300
+145,600
+872% +$3.83M 0.01% 1339
2025
Q1 		$473K Sell
16,700
-200,000
-92% -$7.1M ﹤0.01% 2289
2024
Q4 		$9.01M Buy
216,700
+188,200
+660% +$9M 0.01% 1007
2024
Q3 		$1.9M Buy
28,500
+15,200
+114% +$1.4M ﹤0.01% 1688
2024
Q2 		$1.58M Buy
+13,300
New +$1.68M ﹤0.01% 1617
2023
Q4 		– Sell
-455,000
Closed -$47M – 2746
2023
Q3 		$47M Buy
455,000
+325,000
+250% +$36.3M 0.1% 285
2023
Q2 		$15.8M Buy
+130,000
New +$17.3M 0.03% 612
2022
Q4 		– Sell
-5,000
Closed -$591K – 3057
2022
Q3 		$591K Buy
+5,000
New +$759K ﹤0.01% 1984
2022
Q2 		– Sell
-4,000
Closed -$689K – 3012
2022
Q1 		$689K Sell
4,000
-42,000
-91% -$7.07M ﹤0.01% 1732
2021
Q4 		$11.7M Buy
+46,000
New +$13.4M 0.04% 593
2021
Q3 		– Sell
-2,500
Closed -$587K – 2256
2021
Q2 		$587K Buy
+2,500
New +$447K ﹤0.01% 1497
2020
Q3 		– Sell
-1,600,000
Closed -$103M – 1478
2020
Q2 		$103M Buy
+1,600,000
New +$87.6M 0.89% 8

Other funds holding MRNA

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Capital World Investors
Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return
Baillie Gifford & Co
Baillie Gifford & Co Edinburgh, United Kingdom $110B AUM 4.8% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
TP
Theleme Partners London, United Kingdom $1.68B AUM 19.9% 1-Year Est. Return

Dmitry Balyasny's MRNA Position: Q2 2026 in Review

Dmitry Balyasny increased its Moderna (MRNA) stake by 1,969% in Q2 2026, buying an estimated $5.29M and bringing the position to 107,418 shares worth $7.52M. The position accounts for 0.01% of the portfolio, ranked #1195.

Dmitry Balyasny first reported a position in MRNA in Q2 2019 and has held it in 16 quarters since. The position peaked at $72.3M in Q3 2023. 775 funds tracked by Wall St. Rank hold MRNA as of Q2 2026.

  • Dmitry Balyasny held 107,418 shares of Moderna worth $7.52M as of Q2 2026.
  • Dmitry Balyasny bought 102,227 Moderna shares in Q2 2026, an estimated $5.29M.
  • Moderna made up 0.01% of Dmitry Balyasny's portfolio in Q2 2026, its #1195 holding.
  • Dmitry Balyasny first reported a position in Moderna in Q2 2019 and has held it in 16 quarters since.
  • Dmitry Balyasny's Moderna position peaked at $72.3M in Q3 2023.
  • 775 funds tracked by Wall St. Rank held Moderna as of Q2 2026.

Based on Balyasny Asset Management's 13F filing for Q2 2026, filed 14 Aug 2026.